Table 1.
Baseline characteristics of the entire patients (n = 427).
| Characteristics | No. of patients | Proportion (%) |
|---|---|---|
| Age (years), mean ± SD | 56.7 ± 9.5 | |
| Gender | ||
| Male | 366 | 85.7 |
| Female | 61 | 14.3 |
| Cirrhosis | ||
| Yes | 366 | 85.7 |
| No | 61 | 14.3 |
| Virus hepatitis | ||
| HBV | 359 | 84.1 |
| HCV | 8 | 1.9 |
| Non-HBC, non-HCV | 60 | 14.0 |
| Antiviral treatment∗ | ||
| Yes | 359 | 84.1 |
| No | 68 | 15.9 |
| Child-Pugh | ||
| A | 415 | 97.2 |
| B | 12 | 2.8 |
| ALT (U/L), median (IQR) | 36.0 (25.0–51.0) | |
| T-Bil (umol/L), median (IQR) | 14.8 (11.2–19.4) | |
| Anatomical resection | ||
| Yes | 146 | 34.2 |
| No | 281 | 65.8 |
| Surgical margin (mm) | ||
| ≤10 | 364 | 85.2 |
| >10 | 63 | 14.8 |
| MTD (cm) | ||
| ≤5 | 320 | 74.9 |
| >5 | 107 | 25.1 |
| Number of nodules | ||
| 1 | 363 | 85.0 |
| >1 | 64 | 15.0 |
| Microvascular invasion | ||
| Yes | 91 | 21.1 |
| No | 336 | 78.7 |
| Differentiation | ||
| Well | 50 | 11.7 |
| Mod, poor | 377 | 88.3 |
| TNM stage∗∗ | ||
| I | 328 | 76.8 |
| II | 60 | 14.1 |
| III | 39 | 9.1 |
HBV, viral hepatitis B; HCV, viral hepatitis C; ALT, alanine transaminase; T-Bil, total bilirubin; MTD, maximal tumor diameter; IQR, interquartile range. ∗In this study, out of a total of 427 patients, 359 were HBV-related HCC patients. They were all treated with nucleic acid analog for hepatitis B. ∗∗TNM stages were assigned according to the criteria described in the AJCC Cancer Staging Manual (8th Edition).